We are live on ! Find out more
GCM

Goldman Capital Management Portfolio holdings

AUM $103M
1-Year Est. Return 21.37%
This Fund
S&P 500
This Quarter Est. Return
+0.12%
1 Year Est. Return
+21.37%
3 Year Est. Return
+24.28%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.2M
AUM Growth
-$10M
Cap. Flow
-$7.66M
Cap. Flow %
-8.12%
Top 10 Hldgs %
86.99%
Holding
30
New
–
Increased
5
Reduced
21
Closed
2

Top Buys

Rank Stock Value
1
MLSS icon
Milestone Scientific
MLSS
+$285K
2
SFE
Safeguard Scientifics, Inc.
SFE
+$55.4K
3
DTRM
Determine, Inc. Common Stock
DTRM
+$36.4K

Top Sells

Rank Stock Value
1
AAOI icon
Applied Optoelectronics
AAOI
+$3.4M
2
ACTA
Actua Corp
ACTA
+$1.24M
3
STGW icon
Stagwell
STGW
+$561K
4
CYRN
CYREN Ltd.
CYRN
+$431K
5
PRKR
Parkervision Inc
PRKR
+$403K

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.06%
2 Technology 44.8%
3 Healthcare 2.56%
4 Communication Services 2.38%
5 Consumer Discretionary 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IW
1
DELISTED
IMAGEWARE SYSTEMS,INC
IW
$35.9M 38.07%
35,874,716
-380,000
-1% -$380K
AAOI icon
2
Applied Optoelectronics
AAOI
$9.02B
$11.7M 12.43%
189,600
-58,208
-23% -$3.4M
ACTA
3
DELISTED
Actua Corp
ACTA
$9.22M 9.78%
656,300
-87,844
-12% -$1.24M
TRAK icon
4
ReposiTrak
TRAK
$151M
$5.88M 6.24%
483,869
-26,572
-5% -$327K
CYRN
5
DELISTED
CYREN Ltd.
CYRN
$4.84M 5.13%
117,946
-10,401
-8% -$431K
MATR
6
DELISTED
Mattersight Corp.
MATR
$3.87M 4.11%
1,518,533
-26,730
-2% -$78K
REFR icon
7
Research Frontiers
REFR
$16.1M
$2.69M 2.86%
2,088,623
-69,468
-3% -$87.3K
STGW icon
8
Stagwell
STGW
$2.14B
$2.19M 2.33%
221,700
-65,000
-23% -$561K
APPS icon
9
Digital Turbine
APPS
$1.34B
$1.93M 2.04%
1,870,496
-169,504
-8% -$179K
MLSS icon
10
Milestone Scientific
MLSS
$44.5M
$1.75M 1.86%
1,169,610
+203,800
+21% +$285K
DTRM
11
DELISTED
Determine, Inc. Common Stock
DTRM
$1.36M 1.44%
515,446
+10,907
+2% +$36.4K
CTHR
12
DELISTED
Charles & Colvard Ltd
CTHR
$1.25M 1.32%
135,367
-4,500
-3% -$41.1K
SFE
13
DELISTED
Safeguard Scientifics, Inc.
SFE
$827K 0.88%
69,477
+4,707
+7% +$55.4K
IPAS
14
DELISTED
Ipass Inc Common Stock
IPAS
$661K 0.7%
50,100
-30,000
-37% -$395K
TRIB
15
Trinity Biotech
TRIB
$7.87M
$579K 0.61%
643
-452
-41% -$384K
PURE
16
DELISTED
PURE BIOSCIENCE INC COM STK NEW (DE)
PURE
$187K 0.2%
163,884
-229,366
-58% -$262K
XTNT icon
17
Xtant Medical Holdings
XTNT
$53.9M
$75K 0.08%
9,417
-9,000
-49% -$59.8K
CXDO icon
18
Crexendo
CXDO
$209M
$51K 0.05%
28,000
-14,543
-34% -$26.5K
PRKR
19
DELISTED
Parkervision Inc
PRKR
$36K 0.04%
20,000
-188,800
-90% -$403K
PRSO icon
20
Peraso
PRSO
$9.68M
$27K 0.03%
20
-46
-70% -$48.1K
BIOC
21
DELISTED
Biocept, Inc.
BIOC
– –
-11
Closed -$213K

Similar funds

HIM
Hutchens Investment Management Concord, New Hampshire $106M AUM 27.22% 1-Year Est. Return
MIS
Man Investments (Switzerland) Pfaffikon, Switzerland $107M AUM 0.04% 1-Year Est. Return
CL
Croft-Leominster Baltimore, Maryland $107M AUM 27.94% 1-Year Est. Return
BCSB
Bristol County Savings Bank Taunton, Massachusetts $107M AUM
BGMBH
Burda Gesellschaft mit beschrankter Haftung Offenburg, Germany $113M AUM 0% 1-Year Est. Return
CCM
Conatus Capital Management Greenwich, Connecticut $92.3M AUM 45.31% 1-Year Est. Return
AZA
Arthur Zaske & Associates Bingham Farms, Michigan $91.5M AUM 9.44% 1-Year Est. Return
IT
Independence Trust Franklin, Tennessee $90.5M AUM 24.37% 1-Year Est. Return

Goldman Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Goldman Capital Management held 30 positions worth $94.2M, down 9.6% from $104M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Goldman Capital Management withdrew a net $7.66M in Q2 2017, closing 2 positions and reducing 21 holdings. Its most notable exit was Biocept, Inc., an estimated $213K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 45% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Goldman Capital Management added an estimated $285K to Milestone Scientific.

  • Goldman Capital Management added most to Milestone Scientific in Q2 2017, an estimated $285K increase.
  • Goldman Capital Management's biggest Q2 2017 reduction was Applied Optoelectronics, cutting an estimated $3.4M.
  • Goldman Capital Management fully exited Biocept, Inc. in Q2 2017, selling an estimated $213K.
  • Goldman Capital Management's ten largest holdings make up 87% of its $94.2M portfolio in Q2 2017.
  • Goldman Capital Management opened 0 new positions and closed 2 in Q2 2017.
  • Goldman Capital Management's portfolio value fell 9.6% quarter-over-quarter to $94.2M.

Based on Goldman Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.